Breaking News
Top News
-
Falcon Copper, Glencore to boost US minerals supply chain
-
Prediction: Energy Transfer Will Hit $25 in 2026
-
Bitcoin Spot CVD Surges 199% as Institutional Inflows Re-Accelerate
-
Cove Kaz, Skyline sign merger agreement
-
Lockton obtains Saudi reinsurance licence
-
48% of retirees can’t sustain their lifestyle — and Kevin Warsh’s expected Fed rate cut could make it worse
-
Wall Street Futures Edge Higher After Record Highs as Earnings and Iran Tensions Stay in Focus: Dow Jones, S&P, Nasdaq
-
Yen jumps sharply as Japan warns it is ready to intervene again
-
Gold Prices Linger Near One-Month Lows Amid Iran Tensions and Rate Uncertainty
-
Live Q&A: The U.S. Car Industry Stares Down China—Ask Us Your Questions
-
3 of the Best Consumer Staples Stocks in 2026
-
DTE sees up to 8.4 GW data center opportunity
-
Japan signs first $2.2 billion loan under $550 billion US investment pledge
-
Why Eli Lilly and Company (LLY) is One of the Best Drug Stocks to Buy According to Analysts
-
Is AbbVie Inc. (ABBV) One of the Best Drug Stocks to Buy According to Analysts?
-
Zoetis Inc. (ZTS) Announces Expansion of Capabilities of Vetscan OptiCell
-
Neurocrine Biosciences (NBIX) Announces First Presentation of New Two-Year Data From Phase 3 CAHtalyst® Adult Study
-
RBC Capital Lifts PT BioCryst Pharmaceuticals (BCRX) as Part of Q1 2026 Results Preview in Biotech
-
Kiniksa Pharmaceuticals International (KNSA) Announces Q1 2026 Financial Results
-
ANI Pharmaceuticals (ANIP) Announces Launch of Pimozide Tablets 1 mg and 2 mg
2026-02-05



































